Expertise in
6
conditions

Cedric J. Hermans

Brussels, BRU, BE 
Expertise in
6
conditions
Brussels, BRU, BE 

Overview

Cedric Hermans practices practicing medicine in Brussels, Belgium.

Mr. Hermans is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Hemophilia A, Blood Clots, Hemophilia B, Thrombectomy, and Fasciotomy.

He is actively involved in clinical research, co-authoring 274 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Brussels, BRU, Belgium
Other Locations
Brugge, VLG 8200, Belgium
Antwerpen, VLG, Belgium
Leuven, VLG, Belgium
Yvoir, WAL, Belgium
Belgium

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Haemophilia and Bone Loss PHILEOS Study
Haemophilia and Bone Loss PHILEOS Study
Enrollment Status: Completed
Publish Date: June 03, 2026
Intervention Type: Biological, Radiation
Study Phase: Not Applicable
Phase III, Open-label, Single-dose, Multi-center, Multinational Trial Investigating a Serotype 5 Adeno-associated Viral Vector Containing the Padua Variant of a Codon-optimized Human Factor IX Gene (AAV5-hFIXco-Padua, AMT-061) Administered to Adult Subjects With Severe or Moderately Severe Hemophilia B
Phase III, Open-label, Single-dose, Multi-center, Multinational Trial Investigating a Serotype 5 Adeno-associated Viral Vector Containing the Padua Variant of a Codon-optimized Human Factor IX Gene (AAV5-hFIXco-Padua, AMT-061) Administered to Adult Subjects With Severe or Moderately Severe Hemophilia B
Enrollment Status: Completed
Publish Date: March 27, 2026
Intervention Type: Genetic, Biological
Study Drug: AMT-061 Adeno-Associated Virus Padua Variant FIX Vaccine
Study Phase: Phase 3
View 1 Less Clinical Trial

274 Total Publications

Heterogeneity Among Plasma-Derived von Willebrand Factor Concentrates: Implications for Comparative Effectiveness Analyses.
Heterogeneity Among Plasma-Derived von Willebrand Factor Concentrates: Implications for Comparative Effectiveness Analyses.
Journal: Seminars in thrombosis and hemostasis
Published: May 22, 2026

Frequently Asked Questions about Cedric J. Hermans

Is Cedric J. Hermans a top-rated expert for Hemophilia A?

MediFind is an objective health platform that identifies experts based on real-world data. Cedric J. Hermans is classified as an Elite expert for Hemophilia A, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Cedric J. Hermans participate in research or clinical trials?

Yes. Cedric J. Hermans has published 274 articles and abstracts on conditions like Hemophilia A. You can view a list of Cedric J. Hermans's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Hermans's expertise for a condition
ConditionClose
View All 35 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile